Ingevity Corporation balance sheet NGVT

As of Jun 30, 2026, Ingevity Corporation had total assets of $1.5 billion and total liabilities of $1.5 billion. Total assets were down 18.1% from a year earlier. Stockholders' equity was $46.9 million. It held $97.4 million in cash and investments against $180.1 million of total debt, net debt of $82.7 million. The current ratio, current assets divided by current liabilities, was 1.61.

USD in millions, except ratios and per-share amounts. The percent under a figure is the change from the same quarter a year earlier.

Line
Q2 FY2026
Jun 30, 2026
Q1 FY2026
Mar 31, 2026
Q4 FY2025
Dec 31, 2025
Q3 FY2025
Sep 30, 2025
Q2 FY2025
Jun 30, 2025
Q1 FY2025
Mar 31, 2025
Q4 FY2024
Dec 31, 2024
Q3 FY2024
Sep 30, 2024
Assets
Cash
97
+26.7%
95
+33.4%
78
+14.9%
83
-38.5%
77
-28.4%
72
-19.2%
68
-29.1%
136
+60.4%
Cash and investments
97
+26.7%
95
+33.4%
78
+14.9%
83
-38.5%
77
-28.4%
72
-19.2%
68
-29.1%
136
+60.4%
Inventory
154
-30.1%
204
-17.0%
186
-5.1%
194
-25.8%
220
-27.1%
245
-24.6%
196
-36.6%
261
-32.5%
Total current assets
544
+1.5%
582
+9.8%
454
-7.9%
522
-18.0%
536
-21.8%
530
-20.8%
493
-25.1%
637
-13.3%
Property and equipment, net
575
-12.2%
600
-8.5%
608
-5.4%
630
-6.2%
655
-9.4%
656
-9.7%
643
-15.7%
671
-16.1%
Goodwill
4
+0.0%
4
-97.6%
4
-97.5%
4
-97.7%
4
-97.6%
181
-65.6%
175
-66.8%
187
-64.1%
Total assets
1,538
-18.1%
1,650
-19.7%
1,651
-18.4%
1,834
-17.1%
1,878
-17.5%
2,056
-19.9%
2,023
-22.9%
2,212
-20.1%
Liabilities and equity
Accounts payable
88
-13.3%
85
-21.5%
92
-2.6%
101
+4.6%
102
-28.7%
108
-29.3%
94
-40.3%
96
-51.1%
Total current liabilities
338
-14.1%
409
+54.7%
341
+29.2%
412
+14.1%
393
+9.9%
265
-24.8%
264
-27.2%
361
+18.3%
Total liabilities
1,491
-15.2%
1,611
-11.5%
1,621
-11.3%
1,696
-15.1%
1,757
-11.8%
1,822
-8.9%
1,827
-8.3%
1,997
-2.5%
Stockholders' equity
47
-61.1%
39
-83.4%
30
-84.8%
138
-35.6%
121
-57.6%
235
-58.7%
195
-69.1%
214
-70.2%
Debt
Debt due within a year
144
+52.1%
122
+101.8%
47
-23.2%
102
+1.3%
95
-8.1%
60
-28.7%
61
-27.4%
101
+3256.7%
Lease liabilities
36
-20.1%
40
-17.7%
133
-13.5%
31
-46.6%
45
-25.2%
49
-23.0%
154
-8.7%
58
-15.9%
Total debt
180
+28.7%
162
+48.2%
180
-16.2%
133
-16.2%
140
-14.4%
110
-26.3%
215
-15.0%
159
+120.4%
Net cash
-83
-31.3%
-67
-76.1%
-102
+30.6%
-50
-113.8%
-63
-12.5%
-38
+36.7%
-147
+6.3%
-23
-285.6%
Ratios
Current ratio
1.61x
1.42x
1.33x
1.27x
1.36x
2.00x
1.87x
1.76x
Debt to equity
3.84x
4.17x
6.06x
0.96x
1.16x
0.47x
1.10x
0.74x
Debt to EBITDA
—
—
0.34x
—
—
—
0.40x
0.32x
Return on equity
115.14%
-328.53%
-562.63%
-47.72%
-179.45%
-150.81%
-220.44%
-262.80%
Return on assets
3.51%
-7.74%
-10.12%
-3.59%
-11.54%
-17.21%
-21.27%
-25.49%
Book value per share
1.36
1.12
0.84
3.83
3.31
6.44
5.37
5.90
How these figures are calculated

Quarterly columns are single-quarter amounts. When a 10-Q reports only a year-to-date total, as cash flow statements do, the quarter is that total minus the previous quarter's year-to-date total. The fourth quarter is the annual report's full year minus the first nine months. A column marked YTD is a year-to-date total, shown when the earlier report needed for the single quarter is missing. USD in millions, except ratios and per-share amounts. Cash and investments adds short-term and long-term marketable securities to cash. Debt due within a year is the borrowings that are not already in long-term debt. Total debt is those borrowings plus lease liabilities. Net cash is cash and investments minus total debt. Return on equity and return on assets divide the trailing twelve months of net income by the balance on that date. Debt to EBITDA uses the trailing twelve months of EBITDA. More on our methodology.

Company profile

Industry
Chemicals & Allied Products (SIC 2800)
Listed as
NGVT (NYSE)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
North Charleston, SC
SEC filer status
Large accelerated filer
SEC CIK
1653477

Other Chemicals & Allied Products companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.